Literature DB >> 19142008

Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence.

Francisco González-Sáiz1, Antònia Domingo-Salvany, Gregorio Barrio, Albert Sánchez-Niubó, M Teresa Brugal, Luís de la Fuente, Jordi Alonso.   

Abstract

AIMS: Our aim was to further assess the Severity of Dependence Scale (SDS) validity and to identify the cut-off score for a DSM-IV diagnosis of heroin and cocaine dependence through a cross-sectional survey in Barcelona, Spain.
METHODS: The Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was used as the gold standard. 146 young (18-30 years old) heroin users were recruited from outside the healthcare context, 135 of whom were also current cocaine users. SDS scores were correlated to quantity, frequency and length of drug use.
RESULTS: The SDS cut-off point at which there was optimal discrimination of a DSM-IV diagnosis presence was found to be 3 (i.e., a score of 3 or more) for heroin dependence and 4 for cocaine dependence.
CONCLUSIONS: The study gives further support to SDS dimensional properties and to its validity for rapid assessment of current heroin and cocaine dependence. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19142008     DOI: 10.1159/000189787

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  11 in total

1.  Examining Risk for Frequent Cocaine Use: Focus on an African American Treatment Population.

Authors:  Tamika Chere Barkley Zapolski; Patrick Baldwin; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

2.  Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.

Authors:  M Chahua; A Sánchez-Niubò; M Torrens; L Sordo; M J Bravo; M T Brugal; A Domingo-Salvany
Journal:  Qual Life Res       Date:  2015-02-15       Impact factor: 4.147

3.  Gambling Problems Among Community Cocaine Users.

Authors:  Magali Dufour; Noël Nguyen; Karine Bertrand; Michel Perreault; Didier Jutras-Aswad; Adèle Morvannou; Julie Bruneau; Djamal Berbiche; Élise Roy
Journal:  J Gambl Stud       Date:  2016-09

4.  Health consequences of long-term injection heroin use among aging Mexican American men.

Authors:  Luis R Torres; Charles Kaplan; Avelardo Valdez
Journal:  J Aging Health       Date:  2011-03-30

5.  Drug use disorder (DUD) questionnaire: scale development and validation.

Authors:  Michael Scherer; C Debra Furr-Holden; Robert B Voas
Journal:  Eval Rev       Date:  2013-05-27

6.  Relationship between dispositional mindfulness and substance use: findings from a clinical sample.

Authors:  Sarah Bowen; Matthew C Enkema
Journal:  Addict Behav       Date:  2013-10-29       Impact factor: 3.913

7.  Reward Contingencies Improve Goal-Directed Behavior by Enhancing Posterior Brain Attentional Regions and Increasing Corticostriatal Connectivity in Cocaine Addicts.

Authors:  Patricia Rosell-Negre; Juan-Carlos Bustamante; Paola Fuentes-Claramonte; Víctor Costumero; Juan-José Llopis-Llacer; Alfonso Barrós-Loscertales
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

8.  The Severity of Dependence Scale (SDS) for Codeine: Preliminary Investigation of the Psychometric Properties of the SDS in an Online Sample of Codeine Users From the UK.

Authors:  Paolo Deluca; Michelle Foley; Jacklyn Dunne; Andreas Kimergård
Journal:  Front Psychiatry       Date:  2021-04-01       Impact factor: 4.157

9.  Examination of multilevel domains of minority stress: Implications for drug use and mental and physical health among Latina women who have sex with women and men.

Authors:  Alice Cepeda; Kathryn M Nowotny; Jessica Frankeberger; Esmeralda Ramirez; Victoria E Rodriguez; Tasha Perdue; Avelardo Valdez
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

10.  Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.

Authors:  Glenn-Milo Santos; Janet Ikeda; Phillip Coffin; John E Walker; Tim Matheson; Matthew McLaughlin; Jennifer Jain; Eric Vittinghoff; Steven L Batki
Journal:  PLoS One       Date:  2021-07-15       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.